Equine CCL11 induces eosinophil cytoskeletal reorganization and activation

Inflammation Research

Volumn 55, Issue 1, 2006, Pages 46-52

  Weston, M C ^a   Collins, M E ^a   Cunningham, F M ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Actin polymerisation; CCL11; Equine eosinophils; Migration; Superoxide

Indexed keywords

ACTIN; EOSINOPHIL PEROXIDASE; EOTAXIN; FLUORESCENT DYE; SUPEROXIDE;

ACTIN POLYMERIZATION; ANIMAL CELL; ARTICLE; CELL ADHESION; CELL MIGRATION; CHEMOTAXIS; COLORIMETRY; CONTROLLED STUDY; CYTOSKELETON; EOSINOPHIL; FLOW CYTOMETRY; FLUORESCENCE; HORSE; NONHUMAN; STATISTICAL SIGNIFICANCE;

ACTINS; ANIMALS; CELL ADHESION; CELL MOVEMENT; CHEMOKINE CCL11; CHEMOKINES, CC; CHEMOTACTIC FACTORS, EOSINOPHIL; CHEMOTAXIS; CYTOSKELETON; EOSINOPHILS; FLOW CYTOMETRY; HORSES; HUMANS; SUPEROXIDES; TIME FACTORS;

EID: 31344448340     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-005-0007-3     Document Type: Article

References (31)

1. Gleich GJ. Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol. 2000; 105: 651-63.
2. Broide D, Sriamarao P. Eosinophil trafficking to sites of allergic inflammation. Immunol Rev. 2001; 179: 163-72.
3. Gutierrez-Ramos JC, Lloyd, C, Gonzalo, JA. Eotaxin: from an eosinophilic chemokine to a major regulator of allergic reactions. Immunol Today. 1999; 20: 500-4.
4. Rothenberg ME, Mishra A, Brandt EB, Hogan SP. Gastrointestinal eosinophils. Immunol Rev. 2001; 179: 139-55.
5. Benarafa C, Collins ME, Hamblin AS, Cunningham FM. Role of the chemokine eotaxin in the pathogenesis of equine sweet itch. Vet Rec. 2002; 151: 691-3.
6. Benarafa C, Cunningham FM, Hamblin AS, Horohov DW, Collins ME. Cloning of equine chemokines eotaxin, monocyte chemoattractant protein (MCP)-1, MCP-2 and MCP-4, mRNA expression in tissues and induction by IL-4 in dermal fibroblasts. Vet Immunol Immunopathol. 2000; 76: 283-98.
7. Benarafa C, Collins ME, Hamblin AS, Sabroe I, Cunningham FM. Characterisation of the biological activity of recombinant equine eotaxin in vitro. Cytokine. 2002; 19: 27-30.
8. Benarafa C. Equine eotaxin: Cloning, expression and biological activity. PhD thesis, University of London, 2001.
9. Paavilainen VO, Bertling E, Falck S, Lappalainen P. Regulation of cytoskeletal dynamics by actin-monomer-binding proteins. Trends Cell Biol. 2004; 14: 386-94.
10. Cunningham FM, Vandergrifft E, Bailey SR, Sepulveda MF, Goode NT, Horohov DW. Cloning, expression and biological activity of equine interleukin (IL)-5. Vet Immunol Immunopathol. 2003; 95: 63-72.
11. Foster AP, Cunningham FM. Histamine-induced adherence and migration of equine eosinophils. Am J Vet Res. 1998; 59: 1153-9.
12. Foster AP, McCabe PJ, Sanjar S, Cunningham FM. Agonist-induced adherence of equine eosinophils to fibronectin. Vet Immunol Immunopathol. 1997; 56: 205-20.
13. Foster AP, Cunningham FM. Differential superoxide anion generation by equine eosinophils and neutrophils. Vet Immunol Immunopathol. 1997; 59: 225-37.
14. Foster AP, Lees P, Cunningham FM. Platelet activating factor is a mediator of equine neutrophil and eosinophil migration in vitro. Res Vet Sci. 1992; 53: 223-9.
15. Sklar LA, Omann GM, Painter RG. Relationship of actin polymerization and depolymerization to light scattering in human neutrophils: dependence on receptor occupancy and intracellular Ca++. J Cell Biol. 1985; 101: 1161-6.
16. Tenscher K, Metzner B, Schopf E, Norgauer J, Czech W. Recombinant human eotaxin induces oxygen radical production, Ca(2+)-mobilization, actin reorganization, and CD11b upregulation in human eosinophils via a pertussis toxin-sensitive heterotrimeric guanine nucleotide-binding protein. Blood. 1996; 88: 3195-9.
17. Buckland KF, Williams TJ, Conroy DM. Histamine induces cytoskeletal changes in human eosinophils via the H(4) receptor. Br J Pharmacol. 2003; 140: 1117-27.
18. Fujisawa T, Kato Y, Nagase H, Atsuta J, Terada A, Iguchi K, Kamiya H, Morita Y, Kitaura M, Kawasaki H, Yoshie O, Hirai K. Chemokines induce eosinophil degranulation through CCR-3. J Allergy Clin Immunol. 2000; 106: 507-13.
19. Lundahl J, Moshfegh A, Gronneberg R, Hallden G. Eotaxin increases the expression of CD11b/CD18 and adhesion properties in IL5, but not fMLP-prestimulated human peripheral blood eosinophils. Inflammation. 1998; 22: 123-35.
20. Shahabuddin S, Ponath P, Schleimer RP. Migration of eosinophils across endothelial cell monolayers: interactions among IL-5, endothelial-activating cytokines, and C-C chemokines. J Immunol. 2000; 164: 3847-54.
21. Badewa AP, Hudson CE, Heiman AS. Regulatory effects of eotaxin, eotaxin-2, and eotaxin-3 on eosinophil degranulation and superoxide anion generation. Exp Biol Med. 2002; 227: 645-51.
22. Elsner J, Hochstetter R, Kimmig D, Kapp A. Human eotaxin represents a potent activator of the respiratory burst of human eosinophils. Eur J Immunol. 1996; 26: 1919-25.
23. Elsner J, Petering H, Kluthe C, Kimmig D, Smolarski R, Ponath P, Kapp A. Eotaxin-2 activates chemotaxis-related events and release of reactive oxygen species via pertussis toxin-sensitive G proteins in human eosinophils. Eur J Immunol. 1998; 28: 2152-8.
24. Dulkys Y, Schramm G, Kimmig D, Knoss S, Weyergraf A, Kapp A, Elsner J. Detection of mRNA for eotaxin-2 and eotaxin-3 in human dermal fibroblasts and their distinct activation profile on human eosinophils. J Invest Dermatol. 2001; 116: 498-505.
25. Howard TH, Oresajo CO. The kinetics of chemotactic peptide-induced change in F-actin content, F-actin distribution, and the shape of neutrophils. J Cell Biol. 1985; 101: 078-85.
26. Coates TD, Watts RG, Hartman R, Howard TH. Relationship of F-actin distribution to development of polar shape in human polymorphonuclear neutrophils. J Cell Biol. 1992; 117: 765-74.
27. Chung IY, Kim YH, Choi MK, Noh YJ, Park CS, Kwon do Y, Lee DY, Lee YS, Chang HS, Kim KS. Eotaxin and monocyte chemotactic protein-3 use different modes of action. Biochem Biophys Res Commun. 2004; 314: 646-53.
28. Boehme SA, Sullivan SK, Crowe PD, Santos M, Conlon PJ, Sriramarao P, Bacon KB. Activation of mitogen-activated protein kinase regulates eotaxin-induced eosinophil migration. J Immunol. 1999; 63: 1611-8.
29. Phillips RM, Stubbs VE, Henson MR, Williams TJ, Pease JE, Sabroe I. Variations in eosinophil chemokine responses: an investigation of CCR1 and CCR3 function, expression in atopy, and identification of a functional CCR1 promoter. J Immunol. 2003; 170: 6190-201.
30. Pease JE, Wang J, Ponath PD, Murphy PM. The N-terminal extracellular segments of the chemokine receptors CCR1 and CCR3 are determinants for MIP-1alpha and eotaxin binding, respectively, but a second domain is essential for efficient receptor activation. J Biol Chem. 1998; 273: 19972-6.
31. Mishra RK, Scaife JE, Harb Z, Gray BC, Djukanovic R, Dent G. Differential dependence of eosinophil chemotactic responses on phosphoinositide 3-kinase (PI3K). Allergy 2005; 60: 1204-1207.